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Abstract
Introduction: Knowledge of antiretroviral therapy (ART) among children with HIV depends on open communication with them
about their health and medicines. Guidelines assign responsibility for communication to children’s home caregivers. Other
research suggests that communication is poor and knowledge about ART is low among children on treatment in low-income
countries. This study sought to describe communication about medicine for HIV in quantitative terms from the perspectives of
both children and caregivers. Thereafter, it established the factors associated with this communication and with children’s
knowledge about their HIV medicines.
Methods: We undertook a cross-sectional survey of a random sample of 394 children with HIV on treatment and their caregivers
at nine health facilities in Jinja District, Uganda. We assessed reported frequency and content of communication regarding their
medicines as well as knowledge of what the medicines were for. Logistic regression analysis was used to determine the factors
associated with communication patterns and children’s knowledge of HIV medicines.
Results: Although 79.6% of the caregivers reported that they explained to the children about the medicines, only half (50.8%) of
the children said they knew that they were taking medicines for HIV. Older children aged 1517 years were less likely to
communicate with a caregiver about the HIV medicines in the preceding month (OR 0.5, 95% CI 0.30.7, p0.002). Children
aged 1114 years (OR 6.1, 95% CI 2.813.7, pB0.001) and 1517 years (OR 12.6, 95% CI 4.634.3, pB0.001) were more likely
to know they were taking medicines for HIV compared to the younger ones. The least common reported topic of discussion
between children and caregivers was ‘‘what the medicines are for’’ while ‘‘the time to take medicines’’ was by far the most
mentioned by children.
Conclusions: Communication about, and knowledge of, HIV medicines among children with HIV is low. Young age (less than
15 years) was associated with more frequent communication. Caregivers should be supported to communicate diagnosis and
treatment to children with HIV. Age-sensitive guidelines about the nature and content of communication should be developed.
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Introduction
Globally, an estimated 3.4 million children under 15 years
were living with HIV in 2010 and more than 90% of these
were in sub-Saharan Africa [1]. Children under 15 years
constitute 13% of the estimated 1.2 million people living with
HIV in Uganda. The number of children with HIV receiving
Antiretroviral Therapy (ART) rose from 17,000 in 2008/2009
to 26,669 in 2011 [2]. While the introduction of ART has im-
proved survival among children with HIV, evidence suggests
that sustaining adherence remains a challenge [35]. Com-
monly cited barriers to adherence include factors related to
the patient/caregiver/family (age of the child, misinformation
about HIV status and other unique challenges faced by
children with HIV and their caregivers), factors related to the
drug/medication (the demanding nature of ART treatment)
and those related to the health care system [69]. On the
contrary, communication has been stated to play a very
important role in children’s compliance to medication [35].
A study on disclosure of HIV status and adherence to daily
drug regimens among children with HIV in Uganda found that
children’s adherence motivation came from knowing their
HIV sero status and understanding why they needed the drug
[5]. Children’s knowledge of what the medication is for
and how to take it correctly is largely dependent on their
caregivers and requires open communication with children
about their health and medicines [5,10]. While literature
highlights the importance of communicating with children
about their HIV diagnosis and treatment as they grow older,
so as to enable them to be responsible for their health and
adherence to ART [11,12], there is no consensus on when this
should be done.
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International, regional and national guidelines recommend
that children infected with HIV should be informed about
their diagnosis and treatment [10,1316]. However, there are
different opinions concerning the age at which the process
should start. Whereas the World Health Organization (WHO)
recommends that children of school age (612 years) should
be told their HIV status, the African Network for the Care of
Children Affected by HIV/AIDS (ANECCA) suggests that the
process of informing children can start as early as 57 years
[14,16]. The Uganda National Antiretroviral Treatment Guide-
lines on the contrary recommend that the process should
start as early as seven years [10]. Although the above
guidelines do not specify the content of messages to be
communicated to the infected children, they suggest that the
communication must be done gradually and in a culturally
sensitive manner, with the consent and participation of the
child’s parents or caregivers [14]. The guidelines further
indicate that the communication should be in a simple
language, based on the child’s age and understanding [10].
The Uganda National Policy on HIV Counselling and Testing
stipulates that in no case should the provider or parent/
guardian lie to a child of any age about their diagnosis [13].
All these guidelines emphasize the importance of consider-
ing the maturity of the child, ascribe the responsibility of
disclosure to the caregivers and highlight the supportive role
of the health worker in the communication process.
Despite the presence of guidelines, studies indicate that
caregivers often hesitate to explain to the children what
the treatment is for [5,12,1728]. In Uganda, a study on
disclosure of HIV status to children aged 517 years revealed
that only 29% of the caregivers had explained to their
children about HIV infection and its relationship to their
medication [5]. Another study revealed that 25% of care-
givers were unwilling to disclose to the children that they
were infected with HIV [27].
Previous research on communication about children’s HIV
diagnosis and treatment has focused mainly on health care
providers’ and caregivers’ perspectives on whether to dis-
close and when and how to inform infected children about
their HIV/AIDS diagnosis and treatment [12,17,18,22,29].
However, little is known about children’s perspectives on
communication and their knowledge of their medicines.
This study sought to describe communication about
medicine for HIV in quantitative terms from the perspectives
of both children and caregivers. Thereafter, it established
the factors associated with this communication and with
children’s knowledge about their HIV medicines.
Methods
Study design
This was a cross-sectional survey conducted between
September and December 2011. The survey employed quan-
titative methods of data collection, while qualitative methods
were used in another part of the larger study. The survey
was followed by an ethnographic study that involved follow-
up of a purposively selected sampled number of children
for one year in different social spaces that mainly included
homes, treatment centres and post-test clubs. The ethno-
graphic study adopted participant observation and in-depth
interviews as the main methods of data collection to enable
an in-depth exploration of children’s family situations, com-
munication practices regarding their health and medicines,
their challenges and concerns and how best they can be
supported to live on ART. The results from the follow-up arm
of the study are reported elsewhere.
Study setting
The survey was conducted in nine health facilities providing
ART in Jinja District, Eastern Uganda, where the overall HIV
prevalence was estimated at 5.8% [2]. The District has a
population of more than 380,000 people, with 79.1% living
in rural areas [30]. More than half (56%) of the district’s
total population is aged below 18, of which 11% are orphans
[30]. Subsistence farming, fishing and trading are the main
economic activities in the district. The district has a total
of 69 health facilities comprising 49 Government (public),
17 NGO and 3 Institutional (Army, Police and Prisons) health
units. At the time of the study, six Government and three
private not-for-profit health facilities were providing ART for
children.
Sample size
To determine the proportion of children who knew they were
taking medicines for HIV, we estimated the minimum sample
size of 384 children at a 90% power and 95% confidence level
[31]. It was assumed that the proportion of children with HIV
who knew that they were taking medicines for HIV was not
known.
Participants and recruitment
Children with HIV attending HIV clinics in all the nine health
facilities that were providing ART in the district and their
caregivers were enrolled in the study. Children did not have
to know their HIV diagnosis to be included in the study.
Children were considered eligible if they were aged 817
years, registered in the health facilities, were on HIV medi-
cines and were accompanied by their primary caregivers on
the day of the interview. A primary caregiver was defined as
a person who lived with the child (including but not limited
to biological parents), participated in the child’s daily care
and was the most knowledgeable about the child’s health
and medicine taking [5,32]. Primary caregivers were iden-
tified and screened for eligibility with the help of the
paediatric counsellors.
Sampling and data collection
The number of children with HIV sampled from each facility
were randomly selected using systematic sampling. The HIV
health facility registers where the names of the children are
recorded were used as the sampling frame. The sampling
interval was determined by dividing the total population of
the children with HIV on treatment in the facility with the
number of children to be studied in each facility (N/n). After
obtaining a random start from a table of random numbers,
the interval was followed until the required number of
children from each facility was obtained. Experienced re-
search assistants conducted interviews with each selected
child and caregiver using two separate semi-structured
questionnaires.
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Measures
In this study, the term communication referred to the ver-
bal exchange of information about HIV medicines between
children and their caregivers. Children’s communication prac-
tices (frequency and content of communication) with their
caregivers regarding their medicines and their knowledge of
what the medicines were listed on the questionnaires.
Measures of communication included, but were not limi-
ted to issues of disclosure. Through face-to-face interviews,
children were asked about the number of times they talked
about their medicines with their caregivers in the month
preceding the interview. They were further asked what topics
they discussed most (content) about the medicines with their
caregivers. Content topics included 1) when to take the
medicines, 2) when to stop taking them, 3) how to take the
medicines, 4) side effects and 5) what the medicines were for.
Caregivers were asked about their communication with the
children concerning the medicines based on the opportunities
that presented themselves. They were asked 1) whether they
explained to the children reasons for the repeated visits
to the health facility, 2) whether they explained to the
children about the medicines they were taking, 3) whether
the children understood what the medicines were for, 4)
whether the children had ever asked what the medicines
were for and 5) when they would stop taking them. Regarding
knowledge of HIVmedicines, children were asked if they knew
what the medicines they took daily were for. The question
that captured children’s knowledge of what they were told
the medicines were for was close ended. It had pre-coded
answers that included TB, sickle cell, malaria, HIV, they didn’t
explain anything and other (specify). In addition, the socio-
demographic characteristics of the children were investigated.
Responses were recorded on the questionnaire, which had
multiple-choice possibilities with an option of ‘‘others (please
specify)’’ in case a child or care giver mentioned a response
not captured on the questionnaire.
Data management and statistical analysis
Double data entry validation was performed in Epi-Info
software (version 7.1.2; Centres for Disease Control and
Prevention, Atlanta, GA). After internal consistency checks,
the cleaned data set was exported to STATA version 10.0
(TX, USA) for analysis. Mean and standard deviation (SD)
were used to summarize continuous data. Bivariate analy-
sis was done to identify factors associated with children’s
knowledge of what the medicines were for and communica-
tion about medicines with a caregiver in the preceding
month using odds ratios (OR) and their 95% confidence
intervals (CI). Multivariable logistic regression was done to
identify the independent factors associated with children’s
communication about the medicines and knowledge of what
the medicines were for.
Quality control
The nine ART health facilities were pre-visited to obtain
updated sampling frames. Both the children’s and caregivers’
questionnaires were pre-tested for duration, language, clarity
and sequencing of the questions to ensure their validation and
suitability. The questionnaires were developed in English, and
forward and back translated from Lusoga and Luganda (the
local languages commonly used in the study area) to ensure
reliability and validity. The questionnaires were separately
administered by experienced graduate research assistants
either in the local languages of Lusoga and Luganda or in
English, depending on the language best understood by the
respondents. Prior to data collection, the research assis-
tants were trained in data collection and in the administering
of the questionnaires. Questionnaire data were checked
for completeness and accuracy before leaving the health
facilities. The first author closely supervised the research
assistants during data collection.
Ethical considerations
Ethical clearance was obtained from Makerere University
College of Health Sciences, Higher Degrees, Research and
Ethics Committee and the Uganda National Council for
Science and Technology. Permission to conduct the study
was also obtained from the relevant political, administrative
and technical authorities at the district and health facility
levels. Written informed consent was obtained from care-
givers for their own and children’s participation in the study
after explaining the objectives and procedures of the study
to them. Assent to participate in the study was obtained
from the children. Interviews were held in a private and quiet
environment within the health facility premises. Confidenti-
ality was maintained by the use of a coding system. The
researchers worked closely with specialized paediatric coun-
sellors from each of the nine health facilities where children
with HIV were receiving treatment throughout the study to
offer support and specialized counselling services to children
when the need arose.
During the consenting and assenting process, the purpose
of the research was explained to the caregivers and their
children as a study of children’s understanding and commu-
nication about their health and medicines. Through the entire
fieldwork, the researchers were aware of the sensitivity of
the subject, the study and questions were designed in such
a way that they did not directly ask about HIV/AIDS but
children’s health and medicines. Care was taken not to ask
questions in any way that would suggest or alert the child to
their HIV status if they did not yet know it. The only time
the word ‘‘HIV’’ appeared on the children’s questionnaire
was when children were asked, ‘‘What were you told the
medicines are for?’’ Even in this case, the researchers never
read out the different options but only filled in the children’s
response in the questionnaire, since it was interviewer
administered.
Furthermore, given the sensitive nature of the children’s
condition and status, the issue of medication on which the
study focused was a good pivotal point since it involved a
daily practice in which all the children engaged. The focus on
medicine helped to open up for other subjects related to
taking medicine.
Even in this case, the researchers never used the word
‘‘ARVs’’ but rather used the word medicines. All of this was
done to avoid inadvertent disclosure.
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Results
Socio-demographic characteristics of children
A total of 394 children with HIV were interviewed. Of these,
55.3% were females. The mean age was 12.1 (SD 2.7). Almost
all (93%) were attending school. The majority (52.3%) of the
children lived with caregivers other than their biological
parents. Of the 267 (67.8%) children who were orphans,
144 (53.9%) and 123 (46.1%) were single and double
orphans, respectively. Age groups 1114 and 1517 had
more double orphaned children, 57 (46.3%) and 50 (40.7%)
compared to those aged 810 years.
Socio-demographic characteristics of caregivers of children
with HIV
A total of 393 caregivers of children with HIV were inter-
viewed. Of these, the majority (80.9%) was female. Their
mean age was 40 (SD 11.4). More than three-quarters
(78.4%) had been to school and about half (50.3%) had
attained secondary education and above. The most common
occupation (41.5%) was subsistence farming.
Caregivers’ communication to children regarding their
medicines
The majority of the caregivers (61.3%) reported that they did
not explain to the children why they were taking them to
the health facility or reasons for the repeated visits to the
treatment centres: 313 (79.6%) reported that they explained
to the children about the medicines and 288 (73.3%) said
that their children understood what the medicines were for.
Most (63.9%) reported that their children have never asked
them what the medicines were for and 266 (68%) reported
that their children have never asked them when they will
stop taking medicines (Table 1).
Children’s reports on frequency of communication
regarding medicines
When asked the number of times they talked about the
medicines with their caregivers in the past month, 97 (24.6%)
children reported that they did not talk about their medicines
with their caregivers at all, 186 (47.2%) reported 12 times,
46 (11.7%) reported 35 times, while 65 (16.5%) children
reported having talked about the medicines more than five
times.
Child-related factors associated with frequency of
communication regarding medicines
Through a stepwise backward elimination method, all vari-
ables that were thought to be associated with frequency of
communication regarding HIV medicines between children
with HIV and their caregivers (children’s age, sex, orphan
status, school status and primary caregiver) were considered
for inclusion in the multivariable model (Table 2). Age of the
children was the only variable retained in the model. Older
children (1517 years) were less likely to talk with their care-
givers about their medicines (AOR 0.53, 95% CI 0.310.72,
p0.002).
Children’s reports on content of communication about
medicines
Children were asked whether they talked with their care-
givers about when to take their medicines, when to stop
taking medicines, how to take medicines, side effects of the
medicines and what the medicines were for. This was a close-
ended question and children were given choices from which
they could select an answer. Of the 394 children, 135 (34.3%)
reported that they talked with their caregivers about when
to take their medicines; 115 (29.2%) mentioned that they
talked about when they could stop taking medicines; 60
(15.2%) mentioned about how to take the medicines while,
53 (13.5%) reported that they talked about side effects of the
medicines. Only 31 (7.9%) reported that they had talked of
what the medicines were for.
Children’s knowledge of what the medicines were for
Of the 394 children, 200 (50.8%) reported they were taking
medicines for HIV. Of the 194 who did not report that they
were taking medicines for HIV, 45 (11.4%) said they did not
know why they were taking medicines. The other children
mentioned that they had been told they were taking
medicines for TB 32 (8.1%); sickle cell 18 (4.6%); malaria 29
(7.4%) and other diseases, 70 (17.7%) including flu, coughs,
skin rashes, syphilis, headache, stomach pains, worms, and
measles.
Factors associated with children’s knowledge of what
the medicines were for
The socio-demographic characteristics of the children were
compared with their reported knowledge of what the
medicines were for. The characteristics that were associated
with children’s knowledge of what the medicines were for at
bivariate level (pB0.05) included age of the child, orphan
status and having an aunt as a primary caregiver. These
were considered for inclusion in the multivariable model.
Table 1. Caregivers’ communication to children regarding their
medicines
Characteristic Frequency (N393) Percentage (%)
Caregiver explained to the child why s/he was bringing him/her to
the clinic
Yes 152 38.7
No 241 61.3
Caregiver explained to children about their medicines
Yes 313 79.6
No 80 20.4
Does the child understand what the medicines are for?
Yes 288 73.3
No 105 26.7
Has the child asked what the medicines are for?
Yes 142 36.1
No 251 63.9
Has the child asked when s/he will stop taking medicines?
Yes 127 32.3
No 266 67.7
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Only one variable, the age of the child, was retained in the
final model (Table 3).
Discussion
In this study, we found that children reported generally low
frequencies of communication with their caregivers about
medicines. A quarter reported that they had not discussed
their medicines with their caregivers at all in the past month
and about half said that they had talked about them once
or twice. Frequency of communication about medicines
was significantly associated with age: older children reported
less communication with caregivers than younger ones. Our
finding corroborate other research on family functioning in
the context of paediatric chronic conditions, which found
that increasing child age, especially adolescence, is accom-
panied by attempts to achieve increasing levels of autonomy,
often leading to less parentchild cohesion and poor com-
munication [33]. Research has shown further that moving
towards independence from their parents, adolescents
typically want to make their own choices and have a sense
of control over their lives [9].
‘‘What the medicines are for’’ was the least commonly
reported topic of talk, while ‘‘the time to take the medicines’’
was by far the most mentioned by children. Other studies
[18,34,35], as well as our own findings from the qualitative
part of our research referred to in another paper [36], show
Table 2. Crude odd ratios (COR) and Adjusted odds ratios (AOR) and their 95% CI for factors associated with frequency of
communication regarding medicines
Variable Talked about medicines Did not talk about medicines Crude OR (95% CI) p Adjusted OR (95% CI) p
Sex (n394)
Male 134 (45.1) 42 (43.3) 0.9 (0.61.5) 0.754  
Female 163 (54.9) 55 (56.7)
Age group-years (n394)
810 110 (37.0) 25 (25.8) 1
1114 124 (41.8) 36 (37.1) 0.8 (0.41.4) 0.400  
1517 63 (21.2) 36 (37.1) 0.4 (0.20.7) 0.002 0.53 (0.310.72) 0.002*
Orphan status (n267)
Single orphan 100 (52.1) 44 (58.7) 1.3 (0.72.3) 0.332  
Double orphan 92 (47.9) 31 (41.3)
School status (n394)
Out of school 18 (6.1) 11 (11.3) 2.0 (0.84.5) 0.084  
In school 279 (93.9) 86 (88.7)
Primary caregiver (n394)
Biological parent 86 (29.0) 35 (36.1) 1.4 (0.82.3) 0.187  
*Other 211 (71.0) 62 (63.9)
*Other refers to caregivers children lived with who were not their biological parents.
Table 3. Factors associated with children’s knowledge of HIV medicines
Variable HIV Other illnesses Crude OR (95% CI) p Adjusted OR (95% CI) p
Age group-years (n394)
810 21 (10.7) 114 (57.9) 1
1114 92 (46.7) 68 (34.5) 2.5 (4.014.3) B0.001 6.1 (2.813.7) 0.000*
1517 84 (42.6) 15 (7.6) 33.3 (14.3100.0) B0.001 12.6 (4.634.3) 0.000*
Orphan status (n267)
Single orphan 70 (45.8) 74 (64.9) 2.2 (1.33.7) B0.001  
Double orphan 83 (54.2) 40 (35.1)
Primary caregiver (n394)
Mother 49 (24.9) 72 (36.6) 1.7 (1.12.7) 0.012  
*Other 148 (75.1) 125 (63.4)
Primary caregiver (n394)
Aunt 37 (18.8%) 21 (10.7%) 1.94 (1.053.59) 0.023  
**Other 160 (81.2%) 176 (89.3%)
*Other referred to primary caregivers that children lived with who were not their biological mothers.
**Other referred to primary caregivers that children lived with other than aunt.
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that communication with children in settings such as Uganda
is often directive, rather than participatory, with few oppor-
tunities for questioning, discussion, and joint decision making.
When and how to take the medicines were talked about
with caregivers but the communication was often directive
and one-way, with caregivers instructing and reminding the
children, rather than discussing the bigger issues of diagnosis,
prognosis and lifelong medication. Teenagers would be ex-
pected to know how to take the medicines and to remember
themselves when to take them. So this type of directive
communication is less relevant for them and may explain the
lower frequency for the older age group.
Based on disclosure guidelines and the Uganda National
Policy on HIV Counselling and Testing, all children in our
study were in the age bracket where they should ideally have
known what the medicines they were taking were for
[10,13,14,16]. However, only half the children reported that
the medicines were for HIV/AIDS. This level of knowledge was
higher than that reported by Bikaako-Kajura and colleagues
from another study in Uganda, but their sample was smaller
and it included children as young as five years [5]. A review
of studies of HIV status disclosure to children in resource-
limited countries shows lowest levels in Africa, and lower
levels than we found [37]. That review also discusses the
methodological difficulties of comparing levels of disclosure.
Despite the differences in orphan status and relation to
the caregiver, logistical regression analysis showed that only
age of the child was significantly associated with knowing
that the medicines were for HIV. The importance of age is
consistent with the results of other research on paediatric
disclosure, which found that age remains the strongest
predictor of whether or not the child has been disclosed
to [25,3739]. It is interesting that age is inversely related
to frequency of communication. Older children’s knowledge
of their diagnosis does not seem to be associated with
continuing frequent talk about their medicines with their
caregivers.
A major finding of our study is that there is a clear dis-
crepancy between caregiver and child reports about com-
munication, including reasons for taking medicines. More
than three quarters of caregivers affirmed that they had
explained to the children about the medicines and that the
children understood what the medicines are for and yet only
half the children said they knew that the medicines were
for HIV. The discrepancy could be due to several factors.
Children may have refrained from mentioning that the
medicines were for HIV, having been told to keep the secret
as reported by studies on disclosure [12,40,41]. These studies
noted that caregivers of children living with HIV almost
always impose secrecy on the child about his/her status and
children usually comply. In addition, caregivers in our study
may also have given an optimistic picture of communication.
Nearly two thirds of caregivers reported that children did
not ask what the medicines were for. However, qualitative
research revealed that many children did want to know more
about why they were taking medicines [36]. Either caregivers
ignored children’s curiosity or children actually did not pose
questions directly to their caregivers. In cultural contexts
such as Uganda where communication between adults and
children is constrained, our findings agree with others that
there is a need to develop interventions that promote com-
munication about illness and take into consideration the child’s
age and development, family variables and cultural factors
that influence communication as well as concepts of illness
and death [42]. Vaz and colleagues suggest that interven-
tions should consider how communication takes place within
families to assist families in communicating illness informa-
tion to children [18]. Since age is such a decisive factor in
communication and knowledge about the medicines, there is
particular need for age-sensitive guidelines about the nature
and content of communication.
Our findings indicate missed opportunities where care-
givers could have explained to children their diagnosis or why
they were taking medicines. These include telling children
why they brought them to the treatment centres repeatedly.
About a third of the caregivers reported that the children
had asked what the medicines were for and when they could
stop taking them. Such questions also provide obvious
occasions for communication. Our findings are in agreement
with previous research that demonstrated that even though
children’s questioning and curiosity should have provided
caregivers with an opportunity to have a dialogue with their
children concerning their diagnosis, this did not often occur
[17].
One potential limitation in this study was that data were
based on informant responses, which might be subject to
self-reporting bias. Both children and their caregivers could
have given socially desirable answers. However, the quanti-
tative responses were substantiated by open-ended ques-
tions in the survey qualitative interviews and participant
observation [36].
Despite these limitations, reports from both caregivers
and children helped to uncover the communication gaps and
challenges regarding children’s medicines. The inclusion of
other aspects of communication, such as frequency and
topic, is useful in placing the concern with disclosure in the
broader context of everyday exchanges about medicines.
Conclusions
Children’s communication with caregivers about HIV medi-
cines is infrequent and focused on taking tablets. Knowledge
about the purpose of the medicines among children with
HIV is low. This study reveals that relying on caregivers alone
to communicate messages on diagnosis and treatment to
children with HIV may be insufficient. Our findings suggest
the need for interventions that prepare and support care-
givers for this task. Where caregivers have difficulty assuming
the task, health workers in some cases may assume the
responsibility of explaining to the children, after consultation
with the caregivers.
The WHO guidelines recommend that disclosure happens
around age 6 but this does not commonly occur, as our find-
ings show [16]. Guidelines should suggest how information
can be packaged for the different age groups and how it can
be given in a reassuring way. They should include frequently
asked questions and sensitize caregivers to cues that children
want to know more.
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The assumption made by caregivers that children under-
stand what the medicines are for contrasts with the children’s
own reports and underscores the importance of on-going
communication about ARVs between caregivers and the
children. Talking more frequently about the reasons for taking
medicines in a natural way as the occasion arises may
diminish the apprehension about diagnosis. If it becomes a
pattern to discuss various aspects of medicines regularly, it
will be more likely that children’s understanding will develop
over time as they grow up.
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